| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.5B | $2.8B | $3.1B | $1.7B | $0.9B | $1.0B | $0.9B |
| Cost of Revenue | $0.2B | $0.2B | $0.1B | $0.1B | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.2B | $1.4B | $1.2B | $1.8B | $0.8B | $-0.5B | $0.2B | $0.4B |
| Net Income | $0.8B | $0.9B | $0.8B | $1.2B | $0.6B | $-0.6B | $0.1B | $0.3B |
| EPS (Basic) | $6.10 | $7.16 | $7.10 | $10.28 | $5.00 | $-5.11 | $0.75 | $2.41 |
| EPS (Diluted) | $6.09 | $7.14 | $7.05 | $10.11 | $4.91 | $-5.11 | $0.75 | $2.41 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.7B | $10.9B | $7.7B | $5.6B | $4.3B | $3.7B | $4.1B | $3.5B |
| Current Assets | $0.8B | $0.9B | $0.7B | $1.1B | $0.4B | $0.3B | $0.3B | $0.3B |
| Cash & Equivalents | $0.0B | $0.0B | $0.1B | $0.5B | $0.0B | $0.1B | $0.0B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.0B | $1.0B | $0.7B | $0.6B | $0.5B | $0.3B | $0.4B | $0.3B |
| Stockholders' Equity | $5.7B | $5.1B | $3.9B | $3.1B | $1.9B | $1.3B | $1.8B | $1.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.4B | $2.2B | $1.9B | $2.0B | $1.1B | $0.5B | $0.6B | $0.6B |
| Investing Cash Flow | $-2.2B | $-3.7B | $-3.2B | $-1.0B | $-0.7B | $-0.8B | $-0.9B | $-1.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $1.4B | $0.9B | $-0.5B | $-0.3B | $0.3B | $0.3B | $0.9B |